Association between prostate-specific antigen decline and survival outcomes in patients with metastatic castrate-resistant prostate cancer treated with first line abiraterone acetate

L. Leal da Costa, J. Albuquerque,R. Vicente,D. Silva, C. Baptista, R. Bizarro,J. Moreira-Pinto,J. Godinho, F. Branco, A. Faria, F. Lopes, J.A. Teixeira

European Urology Open Science（2022）

引用 0|浏览1

暂无评分

关键词

prostate-specific cancer,first decline abiraterone acetate,survival outcomes,castrate-resistant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要